Denmark: CathVision raises €13m from Vaekstfonden

CathVision, a medical device company developing a novel artificial intelligence therapeutic platform for cardiac electrophysiology procedures, has completed a venture round of €13m (US$14.4m). The round was from Vaekstfonden, a state investment fund that provides capital and strategic support to diverse companies. The proceeds allow the company to begin multi-centre clinical studies and to complete…